These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12505218)

  • 1. Restenosis: do we need to understand it to treat it?
    Faxon D
    J Am Coll Cardiol; 2002 Dec; 40(12):2090-1. PubMed ID: 12505218
    [No Abstract]   [Full Text] [Related]  

  • 2. To heal without renarrowing: is it possible to make it real?
    Lemos PA
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):661. PubMed ID: 17960634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of in-stent restenosis: towards an in situ treatment?].
    Mazighi M; Gouëffic Y; Scheuble A; Feldman LJ
    Med Sci (Paris); 2004 Jan; 20(1):98-104. PubMed ID: 14770371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug eluting stents--end of restenosis?].
    Groch L
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S59-62. PubMed ID: 15651142
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives.
    Birkenhauer P; Yang Z; Gander B
    J Pharm Pharmacol; 2004 Nov; 56(11):1339-56. PubMed ID: 15525440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting intra-coronary stents: have we got the magic bullet?
    Bhatia V; Bhatia R; Dhindsa S
    J Postgrad Med; 2003; 49(3):291-6. PubMed ID: 14597805
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation of C-reactive protein to restenosis after coronary stent implantation and to restenosis after coronary atherectomy.
    Kawamoto R; Hatakeyama K; Imamura T; Ishikawa T; Date H; Shibata Y; Takenaga M; Asada Y; Eto T
    Am J Cardiol; 2004 Jul; 94(1):104-7. PubMed ID: 15219517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting coronary stents.
    Salam AM; Al Suwaidi J; Holmes DR
    Curr Probl Cardiol; 2006 Jan; 31(1):8-119. PubMed ID: 16389102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents: a new treatment in the prevention of restenosis. Part II: Clinical studies.
    Salu KJ; Bosmans JM; Bult H; Vrints CJ
    Acta Cardiol; 2004 Apr; 59(2):165-77 contd. PubMed ID: 15139658
    [No Abstract]   [Full Text] [Related]  

  • 11. Applying drug-eluting stents in clinical practice.
    King SB
    Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From bench to Paccocath.
    Cremers B; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K23-31. PubMed ID: 22027724
    [No Abstract]   [Full Text] [Related]  

  • 13. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
    Ardissino D; Cavallini C; Bramucci E; Indolfi C; Marzocchi A; Manari A; Angeloni G; Carosio G; Bonizzoni E; Colusso S; Repetto M; Merlini PA;
    JAMA; 2004 Dec; 292(22):2727-34. PubMed ID: 15585732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on drug-eluting stents for prevention of restenosis.
    Lee CH; Tan HC; Lim YT
    Asian Cardiovasc Thorac Ann; 2006 Feb; 14(1):75-82. PubMed ID: 16432127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a platform to evaluate and limit in-stent restenosis.
    Elkins CJ; Waugh JM; Amabile PG; Minamiguchi H; Uy M; Sugimoto K; Do YS; Ganaha F; Razavi MK; Dake MD
    Tissue Eng; 2002 Jul; 8(3):395-407. PubMed ID: 12167226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of magnetic stent on coronary restenosis after percutaneous transluminal coronary angioplasty in dogs.
    Lu A; Jia G; Gao G; Wang X
    Chin Med J (Engl); 2001 Aug; 114(8):821-3. PubMed ID: 11780358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems.
    Kavanagh CA; Rochev YA; Gallagher WM; Dawson KA; Keenan AK
    Pharmacol Ther; 2004 Apr; 102(1):1-15. PubMed ID: 15056495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-eluting stents: efficacy, effectiveness, efficiency and evidence].
    Lázaro y de Mercado P
    Rev Esp Cardiol; 2004 Jul; 57(7):608-12. PubMed ID: 15274844
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications of drug eluting stents].
    Cattan S; Michaud P; Nallet O; Allouch P; Elmamoud R; Leyer F; Osman R
    Ann Cardiol Angeiol (Paris); 2004 Nov; 53(6):335-8. PubMed ID: 15603176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).
    Schofer J; Schlüter M; Gershlick AH; Wijns W; Garcia E; Schampaert E; Breithardt G;
    Lancet; 2003 Oct; 362(9390):1093-9. PubMed ID: 14550694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.